WallStreetZenWallStreetZen

NYSE: CRL
Charles River Laboratories International Inc Stock

Open Broker Account
$210.07-2.92 (-1.37%)
Updated Dec 8, 2022
CRL Price
$210.07
Fair Value Price
N/A
Market Cap
$10.69B
52 Week Low
$181.36
52 Week High
$379.65
P/E
24.37x
P/B
4.07x
P/S
2.52x
PEG
1.31x
Dividend Yield
N/A
Revenue
$3.78B
Earnings
$436.39M
Gross Margin
37.3%
Operating Margin
15.1%
Profit Margin
11.5%
Debt to Equity
1.79
Operating Cash Flow
$614M
Beta
1.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CRL Overview

Charles River Laboratories International, Inc. offers a variety of preclinical and clinical laboratory, gene therapy, and cell therapy services to the Pharmaceutical, Medical Device, and Biotechnology sectors. Charles River was founded in 1947 and is headquartered in Wilmington, MA.

Zen Score

Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CRL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CRL ($210.07) is trading above its intrinsic value of $110.13, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CRL is poor value based on its earnings relative to its share price (24.37x), compared to the US market average (21.39x)
P/E vs Market Valuation
CRL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more CRL due diligence checks available for Premium users.

Be the first to know about important CRL news, forecast changes, insider trades & much more!

CRL News

Valuation

CRL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
24.37x
Industry
37.24x
Market
21.39x
CRL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CRL is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

CRL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.07x
Industry
4.43x
CRL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CRL price to earnings growth (PEG)

For valuing profitable companies with growth potential
CRL is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

CRL's financial health

Profit margin

Revenue
$989.2M
Net Income
$96.5M
Profit Margin
9.8%
CRL's Earnings (EBIT) of $570.83M... subscribe to Premium to read more.
Interest Coverage Financials
CRL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$7.4B
Liabilities
$4.7B
Debt to equity
1.79
CRL's short-term assets ($1.42B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CRL's long-term liabilities ($3.70B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CRL's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CRL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$132.8M
Investing
-$92.2M
Financing
-$51.6M
CRL's operating cash flow ($614.14M)... subscribe to Premium to read more.
Debt Coverage Financials

CRL vs Diagnostic & Research Stocks

TickerMarket Cap1d %P/EP/B
CRL$10.69B-1.37%24.37x4.07x
QGEN$11.20B+0.61%22.99x3.37x
PHG$12.17B-1.55%3.35x0.74x
EXAS$8.17B+0.13%-11.18x2.63x
MEDP$6.53B+1.54%30.91x18.65x

Charles River Laboratories International Stock FAQ

What is Charles River Laboratories International's quote symbol?

NYSE: CRL) Charles River Laboratories International trades on the NYSE under the ticker symbol CRL. Charles River Laboratories International stock quotes can also be displayed as NYSE: CRL.

If you're new to stock investing, here's how to buy Charles River Laboratories International stock.

What is the 52 week high and low for Charles River Laboratories International (NYSE: CRL)?

(NYSE: CRL) Charles River Laboratories International's 52-week high was $379.65, and its 52-week low was $181.36. It is currently -44.67% from its 52-week high and 15.83% from its 52-week low.

How much is Charles River Laboratories International stock worth today?

(NYSE: CRL) Charles River Laboratories International currently has 50,878,656 outstanding shares. With Charles River Laboratories International stock trading at $210.07 per share, the total value of Charles River Laboratories International stock (market capitalization) is $10.69B.

Charles River Laboratories International stock was originally listed at a price of $22.00 in Jun 23, 2000. If you had invested in Charles River Laboratories International stock at $22.00, your return over the last 22 years would have been 854.86%, for an annualized return of 10.8% (not including any dividends or dividend reinvestments).

How much is Charles River Laboratories International's stock price per share?

(NYSE: CRL) Charles River Laboratories International stock price per share is $210.07 today (as of Dec 8, 2022).

What is Charles River Laboratories International's Market Cap?

(NYSE: CRL) Charles River Laboratories International's market cap is $10.69B, as of Dec 9, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Charles River Laboratories International's market cap is calculated by multiplying CRL's current stock price of $210.07 by CRL's total outstanding shares of 50,878,656.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.